Vol 6, Supplement 5 (July 24, 2017): Translational Cancer Research (Focused Issue: Radiobiological Models Towards a Personalized Radiation Oncology)

Preface

Radiobiological models towards a personalized radiation oncology
Marco Durante, Giusi Irma Forte, Giorgio Russo
Translational Cancer Research  
2017;
6
(Suppl 5)
:S759-S760
.

Original Article

Radiobiological characterization of the very high dose rate and dose per pulse electron beams produced by an IORT (intra operative radiation therapy) dedicated linac
Paola Scampoli, Carmela Carpentieri, Marco Giannelli, Vera Magaddino, Lorenzo Manti, Carmen Moriello, Maria Antonietta Piliero, Sergio Righi, Fabio Di Martino
Translational Cancer Research  
2017;
6
(Suppl 5)
:S761-S768
.
Lethal and nonlethal chromosome aberrations by gamma rays and heavy ions: a cytogenetic perspective on dose fractionation in hadron radiotherapy
Michael Cornforth, Igor Shuryak, Bradford Loucas
Translational Cancer Research  
2017;
6
(Suppl 5)
:S769-S778
.

Review Article

Proteomics approaches to investigate cancer radiotherapy outcome: slow train coming
Omid Azimzadeh, Soile Tapio
Translational Cancer Research  
2017;
6
(Suppl 5)
:S779-S788
.
Chromosomal and telomeric biomarkers of normal tissue injury to evaluate risk of degenerative health effects (secondary malignancy, cardiovascular disease) post radiation therapy
Miles J. McKenna, Susan M. Bailey
Translational Cancer Research  
2017;
6
(Suppl 5)
:S789-S794
.
Translational research in radiobiology in the framework of France HADRON national collaboration
Claire Rodriguez-Lafrasse, Yannick Saintigny, François Chevalier, Myriam Bernaudin, Carine Laurent, Frédéric Pouzoulet, Yolanda Prezado, Frédérique Megnin-Chanet, Agnès François, Olivier Guipaud, Michael Beuve, Jacques Balosso
Translational Cancer Research  
2017;
6
(Suppl 5)
:S795-S806
.
Increasing the power of tumour control and normal tissue complication probability modelling in radiotherapy: recent trends and current issues
Francesco Tommasino, Alan Nahum, Laura Cella
Translational Cancer Research  
2017;
6
(Suppl 5)
:S807-S821
.
Repurposing DNA repair factors to eradicate tumor cells upon radiotherapy
Souparno Bhattacharya, Aroumougame Asaithamby
Translational Cancer Research  
2017;
6
(Suppl 5)
:S822-S839
.
Normal tissue tolerance
Wolfgang Dörr, Thomas Herrmann, Klaus-Rüdiger Trott
Translational Cancer Research  
2017;
6
(Suppl 5)
:S840-S851
.
Radiogenomics: the utility in patient selection
Giusi Irma Forte, Luigi Minafra, Valentina Bravatà, Francesco Paolo Cammarata, Debora Lamia, Pietro Pisciotta, Giuseppe Antonio Pablo Cirrone, Giacomo Cuttone, Maria Carla Gilardi, Giorgio Russo
Translational Cancer Research  
2017;
6
(Suppl 5)
:S852-S874
.
Translational research in radiation-induced DNA damage signaling and repair
Jac A. Nickoloff, Mary-Keara Boss, Christopher P. Allen, Susan M. LaRue
Translational Cancer Research  
2017;
6
(Suppl 5)
:S875-S891
.
Generating and grading the abscopal effect: proposal for comprehensive evaluation of combination immunoradiotherapy in mouse models
Daniel K. Ebner, Walter Tinganelli, Alexander Helm, Alessandra Bisio, Palma Simoniello, Francesco Natale, Shigeru Yamada, Tadashi Kamada, Takashi Shimokawa, Marco Durante, the Abscopal Research Collaboration (ARC)
Translational Cancer Research  
2017;
6
(Suppl 5)
:S892-S899
.
Genetically engineered mouse models for studying radiation biology
Katherine D. Castle, Mark Chen, Amy J. Wisdom, David G. Kirsch
Translational Cancer Research  
2017;
6
(Suppl 5)
:S900-S913
.
Nuclear interactions of new ions in cancer therapy: impact on dosimetry
Marta Rovituso, Chiara La Tessa
Translational Cancer Research  
2017;
6
(Suppl 5)
:S914-S933
.

Meta-Analysis

Indoor radon exposure and lung cancer risk: a meta-analysis of case-control studies
Carmine Garzillo, Mariagabriella Pugliese, Filomena Loffredo, Maria Quarto
Translational Cancer Research  
2017;
6
(Suppl 5)
:S934-S943
.

Disclosure:

The supplement “Radiobiological Models Towards a Personalized Radiation Oncology” was commissioned by the editorial office, Translational Cancer Research without any sponsorship or funding. Marco Durante, Giusi Irma Forte and Giorgio Russo served as the unpaid Guest Editors for the supplement.